164 related articles for article (PubMed ID: 17234180)
21. Difference in preventive effects between the phosphodiesterase iv inhibitor rolipram and anti-arthritic drugs on antigen-induced arthritis in mice.
Yamaki K; Li X; Hossain MA; Alam AH; Taneda S; Yanagisawa R; Takano H; Yoshino S
Immunol Invest; 2007; 36(2):131-45. PubMed ID: 17365015
[TBL] [Abstract][Full Text] [Related]
22. Role of matrix metalloproteinases in the inflammatory response in human airway cell-based assays and in rodent models of airway disease.
Birrell MA; Wong S; Dekkak A; De Alba J; Haj-Yahia S; Belvisi MG
J Pharmacol Exp Ther; 2006 Aug; 318(2):741-50. PubMed ID: 16690722
[TBL] [Abstract][Full Text] [Related]
23. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
Manoury B; Nénan S; Guénon I; Lagente V; Boichot E
Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
[TBL] [Abstract][Full Text] [Related]
24. Acute pulmonary inflammation induced by exposure of the airways to staphylococcal enterotoxin type B in rats.
Desouza IA; Franco-Penteado CF; Camargo EA; Lima CS; Teixeira SA; Muscará MN; De Nucci G; Antunes E
Toxicol Appl Pharmacol; 2006 Nov; 217(1):107-13. PubMed ID: 16920168
[TBL] [Abstract][Full Text] [Related]
25. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice.
Rijneveld AW; van den Dobbelsteen GP; Florquin S; Standiford TJ; Speelman P; van Alphen L; van der Poll T
J Infect Dis; 2002 Jan; 185(1):123-6. PubMed ID: 11756992
[TBL] [Abstract][Full Text] [Related]
26. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
[TBL] [Abstract][Full Text] [Related]
27. Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model.
Wang YJ; Jiang YL; Tang HF; Zhao CZ; Chen JQ
Int Immunopharmacol; 2010 Feb; 10(2):252-8. PubMed ID: 19914404
[TBL] [Abstract][Full Text] [Related]
28. Changes in bronchoalveolar lavage cells after intratracheal instillation of dimethyl selenide in mice.
Cherdwongcharoensuk D; Upatham S; Oliveira JC; Sousa Pereira A; AGuas AP
Toxicol Pathol; 2004; 32(3):345-50. PubMed ID: 15204977
[TBL] [Abstract][Full Text] [Related]
29. Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice.
Bracke KR; D'hulst AI; Maes T; Demedts IK; Moerloose KB; Kuziel WA; Joos GF; Brusselle GG
Clin Exp Allergy; 2007 Oct; 37(10):1467-79. PubMed ID: 17883726
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma.
Korideck H; Peterson JD
J Pharmacol Exp Ther; 2009 Jun; 329(3):882-9. PubMed ID: 19293392
[TBL] [Abstract][Full Text] [Related]
31. Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
Harada D; Tsukumo Y; Takashima Y; Manabe H
Eur J Pharmacol; 2006 Feb; 532(1-2):128-37. PubMed ID: 16442096
[TBL] [Abstract][Full Text] [Related]
32. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice.
Sato A; Hoshino Y; Hara T; Muro S; Nakamura H; Mishima M; Yodoi J
J Pharmacol Exp Ther; 2008 May; 325(2):380-8. PubMed ID: 18256171
[TBL] [Abstract][Full Text] [Related]
33. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of a novel, orally active PDE4 inhibitor.
Dastidar SG; Ray A; Shirumalla R; Rajagopal D; Chaudhary S; Nanda K; Sharma P; Seth MK; Balachandran S; Gupta N; Palle V
Pharmacology; 2009; 83(5):275-86. PubMed ID: 19321962
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury.
Schuh K; Pahl A
Biochem Pharmacol; 2009 Jun; 77(12):1827-34. PubMed ID: 19428337
[TBL] [Abstract][Full Text] [Related]
36. p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
Medicherla S; Fitzgerald MF; Spicer D; Woodman P; Ma JY; Kapoun AM; Chakravarty S; Dugar S; Protter AA; Higgins LS
J Pharmacol Exp Ther; 2008 Mar; 324(3):921-9. PubMed ID: 18056868
[TBL] [Abstract][Full Text] [Related]
37. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK
Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529
[TBL] [Abstract][Full Text] [Related]
38. Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia.
Spond J; Chapman R; Fine J; Jones H; Kreutner W; Kung TT; Minnicozzi M
Pulm Pharmacol Ther; 2001; 14(2):157-64. PubMed ID: 11273798
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles.
Cho WS; Choi M; Han BS; Cho M; Oh J; Park K; Kim SJ; Kim SH; Jeong J
Toxicol Lett; 2007 Dec; 175(1-3):24-33. PubMed ID: 17981407
[TBL] [Abstract][Full Text] [Related]
40. Early timing of low-dose dexamethasone decreases inflammation in a murine model of eosinophilic airway disease.
Georén SK; Tcacencu I; Wikström AC; Stierna P
Acta Otolaryngol; 2009 Feb; 129(2):182-9. PubMed ID: 18607910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
